- Home
- DIT vs SLS Comparison
DIT vs SLS Comparison
Compare DIT & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- SLS
- Stock Information
- Founded
- DIT 1981
- SLS 2012
- Country
- DIT United States
- SLS United States
- Employees
- DIT N/A
- SLS N/A
- Industry
- DIT Food Distributors
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- SLS Health Care
- Exchange
- DIT Nasdaq
- SLS Nasdaq
- Market Cap
- DIT 78.7M
- SLS 89.6M
- IPO Year
- DIT 1995
- SLS N/A
- Fundamental
- Price
- DIT $119.00
- SLS $1.09
- Analyst Decision
- DIT
- SLS
- Analyst Count
- DIT 0
- SLS 0
- Target Price
- DIT N/A
- SLS N/A
- AVG Volume (30 Days)
- DIT 222.0
- SLS 811.7K
- Earning Date
- DIT 04-17-2025
- SLS 05-13-2025
- Dividend Yield
- DIT 0.85%
- SLS N/A
- EPS Growth
- DIT N/A
- SLS N/A
- EPS
- DIT 5.93
- SLS N/A
- Revenue
- DIT $2,202,495,291.00
- SLS N/A
- Revenue This Year
- DIT N/A
- SLS N/A
- Revenue Next Year
- DIT N/A
- SLS N/A
- P/E Ratio
- DIT $19.81
- SLS N/A
- Revenue Growth
- DIT 7.62
- SLS N/A
- 52 Week Low
- DIT $107.21
- SLS $0.77
- 52 Week High
- DIT $184.00
- SLS $1.84
- Technical
- Relative Strength Index (RSI)
- DIT 42.52
- SLS 40.56
- Support Level
- DIT $107.21
- SLS $1.13
- Resistance Level
- DIT $125.48
- SLS $1.25
- Average True Range (ATR)
- DIT 3.65
- SLS 0.07
- MACD
- DIT -0.47
- SLS -0.01
- Stochastic Oscillator
- DIT 54.99
- SLS 17.39
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.